OZEMPIC Novo Nordisk Pharmaceuticals Pty Ltd

Ozempic (semaglutide) is proposed to improve claudication in adults with type 2 diabetes and poor blood flow in the legs (a condition called peripheral arterial disease). Claudication refers to pain, cramping, or fatigue in muscles - most often in the legs - that occurs during physical activity and subsides with rest.